Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   
National Institute on Drug Abuse News Release NIDA Information
RELEASED, December 29, 1999

NIDA Announces Second-Round Competition For National Drug Abuse Treatment Clinical Trials Network


The National Institute on Drug Abuse (NIDA), National Institutes of Health, announces the release of the second request for grant applications (RFAs) for participation in the National Drug Abuse Clinical Trials Network (CTN). Launched in January 1999, the CTN provides a critically needed research infrastructure that will test and disseminate science-based addiction treatments in real-life settings throughout the country.

NIDA-supported scientists have made considerable progress in developing new and improved pharmacological and behavioral treatments for drug addiction. Many of these new treatments are not yet widely used in practice. By fostering partnerships among NIDA, treatment researchers, and community-based treatment programs, the CTN will rapidly move promising science-based drug addiction treatments into community settings.

In September 1999, NIDA awarded the first five grants to initiate the Clinical Trials Network to establish regional research treatment centers (RRTCs). Recipients included the Health Sciences University of Oregon; the University of California, Los Angeles; Yale University; the University of Pennsylvania; and The Johns Hopkins University.

This latest RFA is the second released this year to develop a geographically diverse and encompassing national Drug Abuse Treatment Clinical Trials Network. When complete, the network will consist of 20 to 30 RRTCs. At the local level, each center will be linked with 10 to 15 community-based treatment programs (CTPs) that represent a variety of treatment settings and patient populations available in that particular region of the country.

The RFA invites cooperative agreement applications from established clinical investigators interested in participating in the CTN. Letters of intent are due by February 17, 2000, with completed applications due by March 16, 2000. For further information on programmatic issues of the CTN, contact Dr. Jack Blaine at 301-443-0107 or Dr. Betty Tai at 301-443-2397.

NIDA supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. The Institute also carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on health effects of drugs of abuse and other topics can be ordered free of charge in English and Spanish, by calling NIDA Infofax at 1-888-NIH-NIDA (-644-6432) or 1-888-TTY-NIDA (-889-6432) for the deaf. These fact sheets and further information on NIDA research and other activities can be found on the Home page at http://www.nida.nih.gov/.


The National Institute on Drug Abuse
is a component of the National Institutes of Health,
U.S. Department of Health and Human Services

News Release Index



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal